Quarterly Earnings Reviews, Market Activity and Upcoming Conference - Research Reports on Under Armour, Altria, Michael Kors, Allstate and U.S. Bancorp

NEW YORK, August 5, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Under Armour, Inc. (NYSE: UA), Altria Group Inc. (NYSE: MO), Michael Kors Holdings Limited (NYSE: KORS), The Allstate Corporation (NYSE: ALL) and U.S. Bancorp (NYSE: USB). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5451-100free.

Under Armour, Inc. Research Reports
On July 24, 2014, Under Armour, Inc. (Under Armour) announced its Q2 2014 financial results and also raised its full-year 2014 net revenue and operating income outlook. In Q2 2014, the Company's net revenue increased 34.1% YoY to $609.7 million, helped by strong growth in Apparel and Footwear segments. The Company's net income remained nearly flat at $17.7 million, or $0.08 per diluted share, compared with the year ago period. Under Armour's Chairman and CEO, Kevin Plank said, "The broad-based momentum that we have been experiencing recently showed no signs of stopping during the second quarter." Under Armour now expects full-year 2014 revenue to be in range of $2.98 billion to $3.0 billion, compared with previously forecasted range of $2.88 billion to $2.91 billion. Also, 2014 operating income is now seen in range of $343 million to $345 million, as against $331 million to $334 million expected earlier. The full research reports on Under Armour are available to download free of charge at:

http://www.analystsreview.com/Aug-05-2014/UA/report.pdf

Altria Group Inc. Research Reports
On July 22, 2014, Altria Group Inc. (Altria) announced its Q2 2014 financial results. Altria's Q2 2014 net revenues decreased by 0.8% YoY to $6.3 billion. Total cigarette shipment volume at Altria fell 5.0% to 32,134 million sticks in Q2 2014. Net earnings attributable to Altria stood at $1.26 billion, or $0.64 per share, in Q2 2014, compared with $1.27 billion, or $0.63 per share, a year earlier. On an adjusted basis, the Company reported EPS of $0.65, which missed the Reuters' adjusted EPS consensus estimate by a cent. Altria revised its full-year 2014 reported diluted EPS guidance from a range of $2.53 to $2.60 to a range of $2.54 to $2.59. The full-year 2014 adjusted diluted EPS guidance range has also been revised to $2.54 to $2.59, versus $2.52 to $2.59 forecasted earlier. In addition, Altria also announced a new $1 billion share repurchase program to be completed by the end of 2015. The full research reports on Altria are available to download free of charge at:

http://www.analystsreview.com/Aug-05-2014/MO/report.pdf

Michael Kors Holdings Limited Research Reports
On July 31, 2014, the stock of Michael Kors Holdings Limited (Michael Kors) declined 0.96% to end the trading session at $81.48. During the session, the stock opened at $83.27, and fluctuated in a range of $81.25 - $83.27, with a total of 3.66 million shares changing hands. Over the last one month, the stock of Michael Kors has declined by 8.09%, compared to the Dow Jones Industrial Average which fell 1.56% during the same period. The full research reports on Michael Kors are available to download free of charge at:

http://www.analystsreview.com/Aug-05-2014/KORS/report.pdf

The Allstate Corporation Research Reports
On July 30, 2014, The Allstate Corporation (Allstate) announced its Q2 2014 financial results. Allstate reported a net income available to common shareholders of $614 million, or $1.39 per diluted share, for Q2 2014, compared to $434 million, or $0.92 per diluted share, a year earlier. However, the Company's operating income fell to $445 million, or $1.01 per diluted share, from $529 million, or $1.12 per diluted share, in Q2 2013, mainly due to higher catastrophe losses of $936 million. Consolidated revenue of the Company rose 0.8% YoY to $8.9 billion. Commenting on the performance, Allstate's Chairman, President and CEO, Thomas J. Wilson said, "Allstate delivered strong results in the second quarter through continued focus on our five 2014 operating priorities." Premium growth was driven by all three brands which underwrite insurance; Allstate brand premiums increased 5.0%, Encompass premiums improved 8.3% and Esurance premiums climbed 15.3%, compared with Q2 2013. The full research reports on Allstate are available to download free of charge at:

http://www.analystsreview.com/Aug-05-2014/ALL/report.pdf

U.S. Bancorp Research Reports
On July 31, 2014, U.S. Bancorp announced that John Elmore, Vice Chairman of community banking and branch delivery and Kent Stone, Vice Chairman of consumer banking and sales support, are scheduled to make presentation at the InvestMNt conference sponsored by the CFA Society of Minnesota. The presentation will begin at 11:15 a.m. CDT on August 6, 2014, in Minneapolis, which will include information about U.S. Bancorp's financial performance and corporate strategies. The full research reports on U.S. Bancorp are available to download free of charge at:

http://www.analystsreview.com/Aug-05-2014/USB/report.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

EDITOR'S NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review